Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda — Clinical Trial Site

7 Registered trials

1 Currently recruiting

Organisation

Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda

Location

Majadahonda, Spain

Identifier

ORG-100048023

Address

Calle De Joaquin Rodrigo 2, 28222, Spain

Departments

#5405 :neurologia
Cirugía General y del Aparato Digestivo
Medical Oncology
Neurology
Oncología
Oncology

Clinical trials at this site (7)

Search interface

Efficacy of amoxicillin/clavulanic acid after surgical drainage of perianal abscess in the prevention of the development of anal fistula. A … Pending

2024-520193-35-00 Patients who underwent surgery for their first episode 6
A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Ca… Recruiting

2022-501703-27-00 Advanced or Metastatic Non-Clear Cell Renal Cell Carcin 5 2023-07-05
An open-label extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with RMS Ended

2023-507906-15-00 Relapsing multiple sclerosis (RMS) 5 2019-01-30
A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab… Ended

2023-507317-10-00 Locally advanced, unresectable, or metastatic non small 5 2021-05-10
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (AcceleRET-Lung) Ended

2023-505035-12-00 RET fusion−positive, metastatic Non-Small Cell Lung Can 5 2020-06-12
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Parti… Ended

2023-506859-13-00 Anaplastic lymphoma kinase (ALK)-positive non-small cel 5 2014-09-09
A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients with Early Parkinson's Dise… Ended

2022-502207-30-01 Parkinson's Disease 4